-
Change Request
-
Resolution: Not Persuasive
-
Highest
-
US Pharmaceutical Quality/Chemistry, Manufacturing and Controls (PQ-CMC) (FHIR)
-
1.0.0-ballot
-
Biomedical Research & Regulation
-
Description and Composition of the Drug Product (3.2.P.1)
-
-
Smita Hastak / Norman Gregory : 15 - 0 - 0
Consider adding all the drug products that would be submitted in a P section of eCTD 3.2 in one bundle.
- is voted on by
-
BALLOT-64711 Affirmative - CatherineHosage Norman : 2024-May-FHIR IG PQ CMC E1 STU
- Balloted